eTox IMI Overview_0511 T Steger-Hartmann

First Page		Document Content
Date: 2011-06-24 21:29:20 Pharmacology Pharmacy European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Etox Pre-clinical development Boehringer Ingelheim Servier Validation Pharmaceutical sciences Pharmaceutical industry Science		eTox IMI Overview_0511 T Steger-Hartmann Add to Reading List Source URL: www.axlr8.eu Download Document from Source Website File Size: 1,55 MB Share Document on Facebook

	PDF Document DocID: 1x9Mp - View Document
	PDF Document DocID: 1wU5z - View Document
	PDF Document DocID: 1wnTX - View Document
	WeHealth by Servier et l’UCSF signent un partenariat pour identifier les startups les plus prometteuses dans le domaine de la santé connectée Paris, France et San Francisco, États-Unis, 12 avril 2018 – WeHealth by DocID: 1v65e - View Document
	EUROPEAN COMMISSION DG Competition CASE AT.39612 – Perindopril (Servier) (Only the English and French texts are authentic) DocID: 1t4Ka - View Document